Journal of Neurology

, Volume 260, Issue 7, pp 1743–1747 | Cite as

Fasciculation anxiety syndrome in clinicians

  • Neil G. Simon
  • Matthew C. KiernanEmail author
Original Communication


The goal of this study is to define the clinical features, pathogenesis and key investigation findings of fasciculation anxiety syndrome in clinicians (FASICS). Twenty consecutive clinicians presenting with fasciculations were prospectively assessed with serial clinical and neurophysiological evaluations. Clinicians with fasciculations formed three groups: 70 % of clinicians experienced symptomatic fasciculations and anxiety about the possibility of amyotrophic lateral sclerosis (ALS), termed FASICS; a further 15 % of clinicians experienced fasciculations associated with cramps and consistent with cramp-fasciculation syndrome (CFS). The final 15 % of clinicians presented with fasciculations associated with sensory symptoms or muscle weakness and were diagnosed with neuropathy (10 %) and ALS (5 %). In FASICS, fasciculations most often involved the lower limbs, without evidence of muscle weakness on clinical examination. Exercise, stress, fatigue and caffeine consumption were identified as common exacerbating factors. Neurophysiological studies confirmed normal nerve conduction studies and the presence of simple fasciculations, without acute denervation or neurogenic motor unit changes. Antibodies to voltage-gated potassium channels were assayed in each clinician and were not detected, and systemic autoantibodies were detected only in clinicians with features of CFS. FASICS is a disorder common among physicians presenting for evaluation of fasciculations. The present study delineates the diagnostic features of FASICS and contrasts the clinical presentation with other causes of fasciculations in clinicians.


Fasciculations Amyotrophic lateral sclerosis Anxiety Benign fasciculation syndrome Cramp-fasciculation syndrome Peripheral nerve hyperexcitability 



We gratefully acknowledge Professor Angela Vincent (Oxford, UK) for performing anti-VGKC antibody testing. Funding from the National Health and Medical Research Council of Australia and the Motor Neurone Disease Research Institute of Australia is gratefully acknowledged.

Conflicts of interest

The authors declare they have no conflict of interest.

Ethical standard

The study was approved by the South East Sydney Area Health Service Human Research Ethics Committee.


  1. 1.
    Blexrud MD, Windebank AJ, Daube JR (1993) Long-term follow-up of 121 patients with benign fasciculations. Ann Neurol 34:622–625PubMedCrossRefGoogle Scholar
  2. 2.
    de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, Mills K, Mitsumoto H, Nodera H, Shefner J, Swash M (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119:497–503PubMedCrossRefGoogle Scholar
  3. 3.
    de Carvalho M, Swash M (2004) Cramps, muscle pain, and fasciculations: not always benign? Neurology 63:721–723PubMedCrossRefGoogle Scholar
  4. 4.
    Dratcu L (2000) Panic, hyperventilation and perpetuation of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 24:1069–1089PubMedCrossRefGoogle Scholar
  5. 5.
    Dumitru D, Diaz CA, King JC (2001) Prevalence of denervation in paraspinal and foot intrinsic musculature. Am J Phys Med Rehabil 80:482–490PubMedCrossRefGoogle Scholar
  6. 6.
    Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895PubMedCrossRefGoogle Scholar
  7. 7.
    Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C, Newsom-Davis J (1997) Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 41:238–246PubMedCrossRefGoogle Scholar
  8. 8.
    Hoehn-Saric R, McLeod DR, Funderburk F, Kowalski P (2004) Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study. Arch Gen Psychiatry 61:913–921PubMedCrossRefGoogle Scholar
  9. 9.
    Huynh W, Kiernan MC (2011) Nerve conduction studies. Aust Fam Physician 40:693–697PubMedGoogle Scholar
  10. 10.
    Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241–255PubMedCrossRefGoogle Scholar
  11. 11.
    Jansen PH, van Dijck JA, Verbeek AL, Durian FW, Joosten EM (1991) Estimation of the frequency of the muscular pain-fasciculation syndrome and the muscular cramp-fasciculation syndrome in the adult population. Eur Arch Psychiatry Clin Neurosci 241:102–104PubMedCrossRefGoogle Scholar
  12. 12.
    Kiernan MC, Hart IK, Bostock H (2001) Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 70:56–64PubMedCrossRefGoogle Scholar
  13. 13.
    Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955PubMedCrossRefGoogle Scholar
  14. 14.
    Kimura J (2001) Electrodiagnosis in diseases of nerve and muscle: principles and practice. Oxford University Press, New YorkGoogle Scholar
  15. 15.
    Layzer RB (1994) The origin of muscle fasciculations and cramps. Muscle Nerve 17:1243–1249PubMedCrossRefGoogle Scholar
  16. 16.
    Medical Research Council (1976) Aid to the examination of the peripheral nervous system. Her Majesty’s Stationary Office, LondonGoogle Scholar
  17. 17.
    Mills KR (2010) Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome. Brain 133:3458–3469PubMedCrossRefGoogle Scholar
  18. 18.
    Mitsikostas DD, Karandreas N, Coutsopetras P, Piperos P, Lygidakis C, Papageorgiou C (1998) Fasciculation potentials in healthy people. Muscle Nerve 21:533–535PubMedCrossRefGoogle Scholar
  19. 19.
    Mogyoros I, Kiernan MC, Burke D, Bostock H (1997) Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain 120(Pt 2):317–325PubMedCrossRefGoogle Scholar
  20. 20.
    Newsom-Davis J, Mills KR (1993) Immunological associations of acquired neuromyotonia (Isaacs’ syndrome). Report of five cases and literature review. Brain 116(Pt 2):453–469PubMedCrossRefGoogle Scholar
  21. 21.
    Reed DM, Kurland LT (1963) Muscle fasciculations in a healthy population. Arch Neurol 9:363–367PubMedCrossRefGoogle Scholar
  22. 22.
    Roth G, Magistris MR (1987) Neuropathies with prolonged conduction block, single and grouped fasciculations, localized limb myokymia. Electroencephalogr Clin Neurophysiol 67:428–438PubMedCrossRefGoogle Scholar
  23. 23.
    Rubio-Agusti I, Perez-Miralles F, Sevilla T, Muelas N, Chumillas MJ, Mayordomo F, Azorin I, Carmona E, Moscardo F, Palau J, Jacobson L, Vincent A, Vilchez JJ, Bataller L (2011) Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients. Neurology 76:172–178PubMedCrossRefGoogle Scholar
  24. 24.
    Schwab RS, Stafford-Clark D, Prichard JS (1951) The clinical significance of fasciculations in voluntary muscle. Br Med J 2:209–212PubMedCrossRefGoogle Scholar
  25. 25.
    Singh V, Gibson J, McLean B, Boggild M, Silver N, White R (2011) Fasciculations and cramps: how benign? Report of four cases progressing to ALS. J Neurol 258:573–578PubMedCrossRefGoogle Scholar
  26. 26.
    Tahmoush AJ, Alonso RJ, Tahmoush GP, Heiman-Patterson TD (1991) Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 41:1021–1024PubMedCrossRefGoogle Scholar
  27. 27.
    Turner MR, Chen Z (2010) The internet for self-diagnosis and prognostication in ALS. Amyotroph Lateral Scler 11:565–567PubMedCrossRefGoogle Scholar
  28. 28.
    Vernino S, Lennon VA (2002) Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26:702–707PubMedCrossRefGoogle Scholar
  29. 29.
    Warwick H (2004) Treatment of health anxiety. Psychiatry 3:80–83CrossRefGoogle Scholar
  30. 30.
    Winhammar JM, Rowe DB, Henderson RD, Kiernan MC (2005) Assessment of disease progression in motor neuron disease. Lancet Neurol 4:229–238PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Neuroscience Research Australia and Prince of Wales Clinical SchoolUniversity of New South WalesRandwickAustralia

Personalised recommendations